Flemming Ornskov, the former chief of Shire PLC, which was absorbed this year by Takeda Pharmaceutical Co. Ltd., has reappeared as head of Nestle Skin Health SA – newly rebranded as Galderma – with a remit to spearhead and grow the dermatology group’s presence in the US and China.
The Dane and former physician headed rare disease specialist Shire from April 2013 until it was bought this year by Takeda. In that five-year period he oversaw huge expansion at Shire, growing its revenues – through organic growth and acquisitions – from $4bn to $15bn
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?